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Abstract: Keratinocytes are non-professional immune cells contributing actively to innate immune
responses partially by reacting to a wide range of molecular patterns by activating pattern recognition
receptors. Cytosolic nucleotide fragments as pathogen- or self-derived trigger factors are activating
inflammasomes and inducing anti-viral signal transduction pathways as well as inducing expression
of inflammatory cytokines. We aimed to compare the induced inflammatory reactions in three
keratinocyte cell types—normal human epidermal keratinocytes, the HaCaT cell line and the
HPV-KER cell line—upon exposure to the synthetic RNA and DNA analogues poly(I:C) and
poly(dA:dT) to reveal the underlying signaling events. Both agents induced the expression of
interleukin-6 and tumor necrosis factor α in all cell types; however, notable kinetic and expression
level differences were found. Western blot analysis revealed rapid activation of the nuclear factor κB
(NF-κB), mitogen activated protein kinase and signal transducers of activator of transcription (STAT)
signal transduction pathways in keratinocytes upon poly(I:C) treatment, while poly(dA:dT) induced
slower activation. Inhibition of NF-κB, p38, STAT-1 and STAT-3 signaling resulted in decreased
cytokine expression, whereas inhibition of mitogen-activated protein kinase kinase 1/2 (MEK1/2)
signaling showed a negative feedback role in both poly(I:C)- and poly(dA:dT)-induced cytokine
expression. Based on our in vitro results nucleotide fragments are able to induce inflammatory
reactions in keratinocytes, but with different rate and kinetics of cytokine expression, explained by
faster activation of signaling routes by poly(I:C) than poly(dA:dT).
Keywords: cytosolic nucleotide fragments; keratinocyte; poly(I:C); poly(dA:dT); signal transduction
pathway; interleukin-6; tumor necrosis factor α
1. Introduction
The skin provides the primary interface between the body and the environment and forms a
physical barrier against invading pathogens. Keratinocytes—the main cell type of the epidermis—form
the physical barrier of the stratum corneum and are immunocompetent cells as well, making the
epidermis an active member of the immune system.
Keratinocytes express a wide range of pattern recognition receptors and are responsive to various
pathogen associated molecular patterns [1–4], including RNA and DNA fragments, which have
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been implicated in antiviral defense of keratinocytes [5,6]. Cytosolic RNA and DNA fragments
are also known as pathogen- as well as damage-associated molecular patterns (PAMPs and
DAMPs), which induce innate immune functions of professional and non-professional immune cells.
In non-infectious skin diseases, such as psoriasis, receptors for RNA and/or DNA fragments [7–9],
moreover their activators: self-derived RNA and DNA fragments and RNA:DNA duplexes are
highly abundant in the lesional epidermis [10,11]. During normal cornification, keratinocytes express
deoxyribonucleases (DNases) [12]; however, it was recently shown that reduced keratinocyte DNase
activity in psoriasis results in suppressed DNA degradation and, as a consequence, parakeratosis [13]
and the presence of excess DNA fragments in the cytosol. Similarly, disturbed ribonuclease activities
were described in psoriatic skin [14,15], which might result in excess RNA fragments.
These self-derived fragments activate among others the absent in melanoma 2 (AIM2)
inflammasome [10,16,17] and inflammatory cytokine expression through their receptors in
keratinocytes [7,11,18] initiating inflammatory events. Nucleotide fragment induced reactions have
been studied by using synthetic RNA analogue poly(I:C) and DNA analogue poly(dA:dT), which both
induce type I interferon (IFN-α/β) and inflammatory cytokine expression in keratinocytes [7,18–20].
Poly(I:C) is recognized primarily by toll-like receptor 3 (TLR3) [21], although, TLR3-independent
sensing of poly(I:C) has also been observed with involvement of retinoic acid induced gene I (RIG-I)
and melanoma differentiation-associated gene 5 [22]. Poly(dA:dT) recognition partially overlaps with
poly(I:C) recognition, since RIG-I serves as a receptor after poly(dA:dT) has been transcribed by RNA
polymerase III into double-stranded (ds) RNA molecules [23]. Cyclic GMP-AMP synthase (cGAS),
a newly described cytosolic DNA receptor implicated in antiviral responses, binds dsDNA sequences
independently and activates interferon regulatory factor 3 in cooperation with interferon-γ-inducible
protein 16 [6].
The basal expression of most inflammatory cytokines is low and is regulated in response to
stimuli at the transcriptional level, mediated by transcription factors of the nuclear factor κB (NF-κB),
mitogen activated protein kinases (MAPK) and signal transducers of activator of transcription (STAT)
signal transduction pathways [18], which have been reported to participate in nucleotide-induced
inflammatory cytokine expression in several cell types [23–26]. Poly(I:C) was found to induce NF-κB,
p38 and STAT-1 signaling in keratinocytes, whereas, in melanocytes, poly(dA:dT) induces NF-κB, p38
and c-Jun N-terminal kinase (JNK) signaling, which differentially regulates cytokine expression [18,24].
Although Cheng and coworkers have reported that sensing of poly(I:C) or poly(dA:dT)
and the induced inflammatory reactions after exposure to these molecules partially overlap [22];
no comprehensive data is available for these reactions in keratinocytes. We aimed to compare
poly(I:C)- and poly(dA:dT)-induced inflammatory reactions in keratinocytes and the underlying signal
transduction events. We found that poly(I:C) and poly(dA:dT) induce similar signal transduction
events in keratinocytes; however, the kinetics are faster and the rate of cytokine induction is higher
in response to poly(I:C). Moreover, our results suggest a negative feedback role for the activation of
extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) signaling in keratinocytes, for both
poly(I:C)- and poly(dA:dT)-induced inflammatory signaling.
2. Results
2.1. Keratinocytes Respond to Poly(I:C) and Poly(dA:dT) with Increased Interleukin-6 (IL-6) and Tumor
Necrosis Factor α (TNF-α) Expression
To study cytosolic RNA- and DNA-induced cytokine-expression profiles in keratinocytes, we used
three keratinocyte cell types: normal human epidermal keratinocytes (NHEKs), the HaCaT cell line [27]
and the HPV-KER cell line [28]. Poly(I:C) strongly induced IL-6 and TNF-α expression in all three
cell types, and poly(dA:dT) induced expression in all cell types with slightly different kinetics as well
as expression that was an order of magnitude lower than that observed with poly(I:C) (Figure 1).
Peak expression was observed 3 to 6 h after poly(I:C) transfection, whereas peak expression after
poly(dA:dT) transfection occurred 6 to 12 h after treatment in all cell types studied. Reaction to
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poly(I:C) in HaCaT cells differed significantly from the other cell types (Figure 1A,C). In contrast,
poly(dA:dT)-induced reaction differed in all three cell types (Figure 1B,D). Previously we found that
the HPV-KER cell line and NHEK cells exhibited similar cytokine mRNA expression [28], which agreed
with our finding on the expression kinetics upon poly(I:C) induction.
To study the induced signaling pathways in keratinocytes, we used only the HPV-KER cell line.
HPV-KER cells previously showed similar reactions to NHEKs [28] and HaCaT cells exhibited a
slightly different cytokine-expression profile, moreover HaCaT cells are known to exhibit constant
activation of inflammatory signaling [29], while high intra-individual differences were observed in the
inflammatory inductions of NHEKs.
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determined by the ΔΔCt method, normalized to 18S rRNA expression and compared to the 
expression of the untreated 0 h samples. Data are presented as mean of three independent 
experiments ± standard error. Significance was determined by two-way repeated measurement 
analysis of variance (ANOVA), * p < 0.05 HaCaT vs. NHEK; # p < HaCaT vs. HPV-KER; + p < 0.05 
HPV-KER vs. NHEK; § p < 0.05 vs. 0 h samples within a cell type. 
2.2. Poly(I:C) and Poly(dA:dT) Treatment Induces Nuclear Factor κB (NF-κB), Mitogen Activated Protein 
Kinase (MAPK) and Signal Transducers of Activator of Transcription (STAT) Activation in Keratinocytes 
NF-κB activation in HPV-KER keratinocytes was assessed by an NF-κB–luciferase reporter 
assay (Figure 2A). The kinetic differences of NF-κB activation between poly(I:C) and poly(dA:dT) 
transfected cells resembled the corresponding cytokine expression differences: peak-activation 
occurred at 6 h after poly(I:C) treatment, whereas the peak activation with poly(dA:dT) occurred 24 
Figure 1. Kinetics of expression of the interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α)
cytokines in normal human epidermal keratinocytes (NHEK) and HaCaT and HPV-KER cell lines
upon transfection with 0. 6 µg/mL poly(I:C) (A,C) and poly(dA:dT) (B,D). Relative expre sion was
determined the ∆∆Ct method, normalized to 18S rRNA expression and compared to the expression
of the untreated 0 h samples. Data are presented as mean of three independe t experiments ± standard
error. Significance w s determined by two-way repeated measurement an lysis of variance (ANOVA),
* p < 0.05 HaCaT vs. NHEK; # p < HaCaT vs. HPV-KER; + p < 0.05 HPV-KER vs. NHEK; § p < 0. 5 vs.
0 h sample within a cell type.
2.2. Poly(I:C) and Poly(dA:dT) Treatment Induces Nuclear Factor κB ( F-κB), itogen ctivated Protein
Kinase (MAPK) and Signal Transducers of ctivator of i i i r ti tes
NF-κB acti ti HPV-KER keratinocytes was assessed by an NF-κB–luciferas repo ter assay
(Figure 2A). The kinetic differences of NF-κB activation betwee poly(I:C) and poly(dA:dT) transfected
cells res mbled th corresponding cytoki e expression differences: peak-activation occurred at 6 h
afte poly(I:C) treatment, whereas th peak activation with poly(dA:dT) occurred 24 h after treatment.
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The delayed NF-κB signaling response to poly(dA:dT) was confirmed with detection of phosphorylated
NF-κB inhibitor α (IκBα) by western blot analysis (Figure 2B and Figure S1A).
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Figure 2. Activatio of uclear Factor κB (NF-κB), Mitogen Activated Protein Kinase ( AP ) and
Signal Transducers of Activator of Transcription (STAT) signal transduction path ays in P -KER
cel s upon poly(I:C) or poly(d :dT) transfection assessed by F-κB-luciferase reporter assay ( ) and
western blot analysis (B– ). (A) NF-κB luciferase reporter as ay exhibited faster activation of F-κB
transcription factor upon poly(I:C) treatm nt than poly(dA:dT) treatment. Raw luminescence intensity
value were normalized to the intrinsic co ol renilla activity, nd compare t the 0 h untreated
samples. Data ar presented as m an of thre i depend nt ex riments ± standard error; statistical
significance was assessed by two-way repeated m asur ment ANOVA * p < 0.05, grey: poly(I:C)
treatment compared t untr ated 0 h samples, black: poly(dA:dT) treatment compared to untreated
0 h samples; (B) Increase in phosphorylated NF-κB inhibitor α (IκBα) after poly(I:C) or poly(dA:dT)
treatment, peaking later after poly(dA:dT) treatment than after poly(I:C) treatment, arrow indicate the
lane for phosphorylated IκBα; (C) Phosphorylation of ERK1/2 increases after poly(I:C) or poly(dA:dT)
treatment, peaking later after poly(dA:dT) treatment than after poly(I:C) treatment, arrows indicate
from top to bottom the lanes for phosphorylated ERK1 and ERK2. Phosphorylation of p38 and JNK
was not observed upon poly(I:C) or poly(dA:dT) treatment; (D) Phosphorylation of both STAT-1 and
STAT-3 occurs faster in poly(I:C) treated samples than in poly(dA:dT) treated samples. Western blot
results are representative for at least three independent experiments. Actin was used as loading control.
Western blot analysis of MAP kinase (Figure 2C) and STAT (Figure 2D) pathways showed that
both poly(I:C) and poly(dA:dT) induced the phosphorylation of ERK1/2 and STAT-1 as well as STAT-3
signaling. Densitometric analysis showed a faster phosphorylation of STAT-1 a S T-3 in poly(I:C)
treated samples compared to poly(dA:dT) treatment (Figure S1). In addition, phosphorylation of p38
MAPK and JNK pathways were not affected at the studied time points, which was also confirmed by
densitometric analysis (Figure S1C,D).
Int. J. Mol. Sci. 2018, 19, 774 5 of 13
2.3. Cytokine Expression of Keratinocytes upon Poly(I:C) and Poly(dA:dT) Treatment Relies on NF-κB, p38 and
STAT Signaling
To address the role of the activated signaling routes in poly(I:C)- and poly(dA:dT)-induced
cytokine expression, keratinocytes were pre-incubated with the specific inhibitors of NF-κB (Bay
11-7085), dual specificity mitogen-activated protein kinase kinase1 and 2 (MEK1/2) (PD95089), p38
(SB203580), JNK (SP600125), STAT-1 (fludarabine) and STAT-3 (Stattic) for an hour before transfection
with poly(I:C) or poly(dA:dT).
Time points of sample collection were determined with respect on the peak expression of
cytokines (Figure 1). Inhibition of NF-κB nearly completely abolished both the poly(I:C)- and
poly(dA:dT)-induced expression of IL-6 and TNF-α (Figure 3A).
Although activation could not be confirmed by our western blot results (Figure 2C), inhibition of
p38 signaling resulted in significantly decreased IL-6 and TNF-α expression (Figure 3B). In contrast,
the inhibition of JNK signaling did not affect cytokine expression (Figure 3C). The inhibition of MEK-1
signaling significantly increased the poly(I:C)- and poly(dA:dT)-induced production of IL-6 (Figure 3D),
suggesting a possible negative regulatory role of this pathway.
Specific inhibition of STAT-3 signaling significantly decreased both poly(I:C)- and
poly(dA:dT)-induced cytokine expression (Figure 3F), whereas the inhibition of STAT-1 affected only
IL-6 expression (Figure 3E). Thus, whereas both poly(I:C)- and poly(dA:dT)-induced IL-6 expression
was affected by most of the studied signaling routes, TNF-α expression was only affected by NF-κB,
p38 and STAT-3.
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(A), p38 (B), c-Jun N-terminal kinase (JNK) (C), mitogen-activated protein kinase kinase 1 and2
(MEK1/2) (D), STAT-1 (E) and STAT-3 (F) on poly(I:C) (6 h fter transfection) and poly(dA:dT) (12 h
after transfection) induction of IL-6 (white bars) and TNF-α (grey bars) expression in HPV-KER cells.
Fold change of mRNA expression values were det rmined by the ∆∆Ct method, normalized to 18S
rRNA expression. As all nhibitors were dissolved in dimethyl sulfoxide (DMSO), the relative
l ere co pared to the expres ion levels in samples treated with DMSO + poly(I:C) or
DMSO + poly(dA:dT), respectively. Pol (I:C) and poly(dA:dT) inductio was n every case signifi nt
compared to the untreated control samples; no significant differen e was observed between the
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DMSO + p ly(dA:dT). Data are represented as the mean of three independe t experiments± sta ard
rror; * p < 0.05; ** p < 0.01; *** p < 0.0 1 determined by Student’s t-test.
3. isc ssi
and DNA fragments are known as important PAM s or DAMPs that induce innate immune
processes of professi nal immune cell types, such as macrophages and dendritic cells [23,30–32],
as well as non-professional immune cells, such as keratinocytes [18]. Accumulation of nucleotide
fragments in keratinocytes is involved in the pathogenesis of psoriasis leading to parakeratosis [13],
as well as in the promotion of inflammati n by activating dendritic cells [33] and in the activation of
i flammasomes in keratinocytes [10,17]. However, the induced inflammatory signaling pathways and
how they contribute to cytokine expression in keratinocytes were not previously studied.
In this st y, we characterized innate immune responses of human keratinocytes to the cytosolic
exposure of the dsRNA analogue poly(I:C) and the dsDNA analogue poly(dA:dT). We compared
the IL-6 and TNF-α expression of NHEK, HaCaT [27] and HPV-KER [28] cells after poly(I:C) and
poly(dA: T) exposure. Previously we found that the inflammatory respo ses of the widely used HaCaT
cell line upon exposure to Propionibacterium acnes differ from that of NHEKs, while the HPV-KER
cell line (established and characterized in our laboratory) shows similar inflam atory [28,34] and
ultraviolet-B irradiation-induced responses to NHEKs [35]. In line with our previous findings [28],
we found that the cytokine expression patterns in the HaCaT cells differ significantly from the
responses of HPV-KER and NHEK cells. Moreover, HaCaT cells are thoug t to be less suitable
to study inflam atory signaling pathways due to their constant NF-κB activation [29].
NF-κB, MAPKs an STAT signaling have been reported to participate in nucleotide-fragment-induced
inflammatory cytokine expression in several cell types [22–26]; however, limited information is
available for these signaling events in keratinocytes upon nucleotide fragment induction [18,36].
According to our results, poly(I:C) induces activation of the studied signaling pathways in a shorter
time than poly(dA:dT), and a corresponding shift in cytokine expression peaks was observed. The
difference in peak timing is likely due to direct activation of TLR3 signaling by poly(I:C) [37]; while it
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has been shown that poly(dA:dT) must first be transcribed to RNA before activating NF-κB through
RIG-I dependent sensing [23] (Figure 4).
In addition to poly(I:C)- and poly(dA:dT)-induced NF-κB activation, phosphorylation of ERK1/2,
STAT-1 and STAT-3 was also observed; but phosphorylation of other studied MAPKs (p38 and JNK)
was not affected. In contrast, a previous study using keratinocytes reported poly(I:C) induction of
p38 signaling but no induction of ERK1/2 signaling [18]. In melanocytes, another epidermal cell
type, poly(dA:dT)-induced phosphorylation of p38 and JNK signaling was observed without ERK1/2
activation [24]. These differences might be due to differences in time points used: our study examined
p38 phosphorylation 30 min after poly(I:C) and poly(dA:dT) transfection in HPV-KER cells, whereas the
previous study examined p38 phosphorylation in NHEKs 15 min after treatment, observing a reduction
after 30 min [18]. These results suggest that poly(I:C)- and poly(dA:dT)-induced p38 phosphorylation
might be a rapid event in keratinocytes. Although we could not confirm p38 phosphorylation,
inhibition of p38 signaling during transfection with poly(I:C) or poly(dA:dT) resulted in decreased
IL-6 and TNF-α expression, which is in agreement with a previous report on poly(I:C)-induced TNF-α
expression in keratinocytes [18].
In monocytes and melanocytes, inhibition of ERK1/2 and JNK signaling pathways abolished
nucleotide-induced IL-6 and TNF-α expression [24,38]. In mouse models, the disruption of ERK1/2
signaling by the inhibition of MEK1/2 functions have been shown to have anti-inflammatory
effects [39,40]. In contrast, in our experiments the disruption of ERK1/2 signaling through inhibition of
MEK1/2 kinases increased the expression of the inflammatory mediator IL-6. These results agree with
previous in vivo findings that therapeutic inhibition of MEK1/2 in patients is often accompanied by
an inflammatory skin rash [41]. These results suggest that ERK1/2 signaling—in contrast to other cell
types—has a negative regulatory function in inflammatory reactions in keratinocytes. Previous reports
have already demonstrated similar results: ERK1/2 signaling was shown to negatively regulate NF-κB
activation [42], and inhibition of MEK1/2 led to increased NF-κB, STAT-1 and interferon-regulatory
factor signaling in human keratinocytes [43], altough, we did not observe an increase in NF-κB
activation upon inhibition of ERK1/2 signaling.
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Figure 4. Proposed model of poly(I:C)- and poly(dA:dT)-induced signaling events leading to IL-6 and
TNF-α expression in keratinocytes, based on our results and results of previous reports [21–23,44].
Our results indicate that p ly(I:C) and po y(dA:dT) induce the same inflammatory pathways; however,
the mode of sensing differs, leading to the observed differences in kinetic. The receptors for poly(I:C)
sensing are toll-like receptor 3 (TLR3) [21] and retinoic acid induced gene I (RIG-I) [22]. In contrast,
poly(dA:dT) is transcribed to double-stranded (ds) RNA by RNA polymerase III (Pol III) and is
subsequently sensed by RIG-I [23]. The tra scription step might be responsible for the delayed response
to poly(dA:dT). The receptors activate the NF-κB, MAPK and STAT signaling routes through the adaptor
molecule mitochondrial antiviral signaling protein (MAVS), and, thus, regulate the transcription of
the cytokines.
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STAT signaling is known to be induced by inflammatory cytokines [45] and by poly(I:C)
treatment [18,36]. We found that, in addition to poly(I:C), poly(dA:dT) also induced STAT-1 and STAT-3
signaling in keratinocytes, and that the induction exhibited a delay in activation after poly(dA:dT)
transfection similar to those observed with other pathways. Poly(I:C)-induced STAT-1 activation has
been shown to regulate TLR3 and TNF-α expression [18]. In our experiments, STAT-1 was found
to regulate poly(I:C)- and poly(dA:dT)-induced IL-6 expression, whereas TNF-α was not affected.
Inhibition of STAT-3 abolished both poly(I:C)- and poly(dA:dT)-induced IL-6 and TNF-α expression,
showing the different regulatory functions of each STAT transcription factors.
In this study, we show the similarities as well as the differences in inflammatory signaling
events of keratinocytes induced by dsRNA and dsDNA. Our data revealed that transfection with
the synthetic dsRNA and dsDNA analogues poly(I:C) and poly(dA:dT) induced activation of NF-κB
and STAT signaling, both of which were also shown to be functional in inducing cytokine expression.
Moreover, we showed the negative regulatory role of ERK1/2 signaling in nucleotide-induced cytokine
expression. Although dsRNA and dsDNA are recognized by different sets of receptors, they induce the
same inflammatory signaling pathways in keratinocytes, albeit with different kinetics and magnitude
of activation.
Studies of the last decade have highlighted disturbances in the signal transduction events
in psoriasis that have led to the development of targeted therapeutics against specific signaling
components. However there is still a lack of knowledge on every aspect of these mechanisms.
Our results deepen the existing knowledge and contribute to the understanding of these signaling
events induced in keratinocytes.
4. Materials and Methods
4.1. Cell Culture
NHEK cells, the HaCaT cell line [27] and the HPV-KER cell line established in our laboratory [28]
were used for the experiments. After obtaining written informed consent from investigated individuals,
skin speciments from the Plastic Surgery Unit of our Department were used to separate NHEKs,
as described previously. Investigations were carried out in accordance with the rules of the
Helsinki Declaration, and prior study, the study design was approved by the Human Investigation
Review Board of the University of Szeged (PSO-EDAFN-002, 23 February2015, Szeged, Hungary).
The epidermis was separated from the dermis with overnight incubation in Dispase (Roche Diagnostics,
Manheim, Germany), and keratinocytes were obtained after maceration in 0.25% trypsin. All cell
types were grown in 75 cm 2 cell culture flasks. NHEKs and HPV-KER cells were maintained in
keratinocyte serum-free medium containing epidermal growth factor and bovine pituitary factor
(Gibco Keratinocyte SFM Kit; Life Technologies, Copenhagen, Denmark) and supplemented with 1%
antibiotic/antimycotic solution (PAA Laboratories GmBH, Pasching, Austria) and 1% L-glutamine
(PAA Laboratories). HaCaT cells were grown in DMEM with 4.5 g/L glucose supplemented with 1%
antibiotic/antimycotic solution, 1% L-glutamine and 10% fetal bovine serum at 37 ◦C in a humidified
atmosphere with 5% CO2. The medium was changed every 2 days.
4.2. Stimulation of the Cells
HPV-KER cells, HaCaT cells or third passage NHEKs were seeded into 6-well plates.
After 24 h, cells were transfected with 0.666 µg/mL polydeoxyadenylic acid-polydeoxythymidylic
acid double-stranded homopolymer (poly(dA:dT)) (InvivoGene, San Diego, CA, USA) or with
0.666 µg/mL polyinosinic-polycytidylic acid (poly(I:C)) (Sigma Aldrich, Saint Louis, MO, USA)
using the X-tremeGene 9 transfection reagent (Roche Diagnostics). Cells were harvested at indicated
time points.
For inhibition studies, cells were incubated 1 h prior to poly(dA:dT)/poly(I:C) transfection with
inhibitors for NF-κB (Bay 11-7085, 10 µM; MedChem Express, Monmouth Junction, NJ, USA), STAT-1
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(Fludarabine, 10 µM; Sigma Aldrich), STAT-3 (Stattic, 5 µM; Sigma Aldrich), MEK1 (PD98059, 20 µM;
Sigma Aldrich), JNK (SP600125, 10 µM; Tocris Bioscience, Bristol, UK) and p38 (SB203580, 10 µM;
Tocris Bioscience).
4.3. RNA Isolation and RT-PCR
Cells were harvested in TRIzol® Reagent (Invitrogen Corp., Carlsbad, CA, USA) and total RNA
was isolated following the manufacturer’s instructions. Potential genomic DNA contamination was
removed by using the Turbo DNA-free Kit (Ambion, Life Technologies) according to the manufacturer’s
instructions. 1 µg total RNA was reverse transcribed into cDNA by the iScript cDNA Synthesis Kit
(Bio-Rad Laboratories, Hercules, CA, USA). Real-time RT-PCR experiments were carried out with
the Universal Probe Library system TaqMan probes (Roche Diagnostics) and qPCRBIO Probe Mix
Lo-ROX (PCR Biosystem Ltd., London, UK) on a C1000 Touch Thermal Cycler (Bio-Rad Laboratories),
using primers reported previously [20]. The expression of each gene was normalized to the expression
of the 18S rRNA gene. Relative mRNA levels were calculated by the ∆∆Ct method.
4.4. Detection of NF-κB Induction
Luciferase assays were performed to determine the NF-κB activity in response to poly(dA:dT)
treatment. The HPV-KER cell line was transfected with the NF-κB reporter construct vector pNF-κB-luc
Cis-Reporter Plasmid (Stratagene, La Jolla, CA, USA) and the pGL4.75 [hRluc/CMV] plasmid (Promega,
Madison, WI, USA) with the use of the X-tremeGene9 transfection reagent. The treated cells were
washed twice with PBS, lysed with passive lysis buffer (Biotium, Hayward, CA, USA) and the
luciferase activities in the lysates were measured using the Firefly & Renilla Dual Luciferase Assay
Kit (Biotium) and Thermo Luminoskan Ascent (Thermo Scientific, Rockford, IL, USA), according to
the manufacturer’s instructions. All samples were measured three times and the luciferase activity
derived from the NF-κB-luc plasmid was normalized to the activity of the Renilla luciferase activity
from pGL4.75 [hRluc/CMV] plasmid.
4.5. Western Blot Analysis
Cells were harvested at indicated time points after poly(dA:dT) or poly(I:C) transfection and lysed
in lysis buffer supplemented with 0.5% SDS and 1% Halt™ Protease and Phosphatase Inhibitor Cocktail
(Thermo Scientific). Equal amounts of protein in ProTrack Loading Buffer (Lonza, Basel, Switzerland)
were separated on a 7.5% TGX Fast Cast Gel and transferred to nitrocellulose membrane (0.45 µm;
Bio-Rad Laboratories). After blocking the membrane in 5% non-fat milk in Tris-Buffered Saline
containing 0.2% Tween-20, primary antibodies were incubated overnight at 4 ◦C with constant agitation.
HRP-conjugated secondary antibodies were incubated for 60 min at room temperature. Signal was
visualized with SuperSignal™ West Pico Chemiluminescent Substrate (Thermo Scientific) on a C-Digit
Blot Scanner (LI-COR Corp., Lincoln, NE, USA). Primary antibodies used were phospho-IκBα
(Santa Cruz Biotechnology, Dallas, TX, USA), phospho-ERK1/2 (BioLegend, San Diego, CA, USA),
phospho-STAT-1 (Ser727; Cell Signaling Technology, Danvers, MA, USA), phospho-STAT-3 (Ser727;
Cell Signaling Technology), phospho-JNK (T183/Y185; Bio-Techne, Abingdon, UK) and phospho-p38
alpha (T180/Y182; Bio-Techne).
4.6. Statistical Analysis
Two-way repeated measurement analysis of variance (ANOVA) was used to compare more than
two groups, and one-tailed, paired Student’s t-test was used to compare two groups, as indicated in
the figure legend. Based on at least three independent biological repeats, data are presented as mean
± standard error. Statistical analysis was carried out using Sigma Plot Ver. 13.0, (Systat Software Inc.
Erkrath, Germany) the significance level was set at p ≤ 0.05.
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Abbreviations
IL-6 interleukin-6
TNF-α tumor necrosis factor α
PAMP pathogen associated molecular pattern
DAMP damage associated molecular pattern
DNase deoxyribonuclease
AIM2 absent in melanoma 2
IFN interferon
TLR toll like receptor
RIG-I retinoic acid induced gene I
cGAS cyclic GMP-AMP synthase
ds double-stranded
poly(dA:dT) polydeoxyadenylic acid-polydeoxythymidylic acid double-stranded homopolymer
poly(I:C) Polyinosinic-polycytidylic acid
MAPK mitogen activated protein kinase
JNK c-Jun N-terminal kinase
ERK1/2 extracellular signal-regulated protein kinase 1 and 2
MEK1/2 dual specificity mitogen-activated protein kinase kinase 1 and 2
NF-κB nuclear factor κB
IκBα NF-κB inhibitor α
STAT signal transducer and activator of transcription
NHEK normal human epidermal keratinocyte
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